Issue 26, 2012

A DTTA-ligated uridine–quantum dot conjugate as a bimodal contrast agent for cellular imaging

Abstract

A uridinequantum dot conjugate, a contrast agent for multimodal imaging, was synthesized. Its T1 relaxivity was 655 and 571.2 mM−1 s−1 per particle at 36 °C in phosphate buffered saline at 60 and 200 MHz, respectively. In vitro multimodal images confirmed its uptake by RAW 264.7 cells.

Graphical abstract: A DTTA-ligated uridine–quantum dot conjugate as a bimodal contrast agent for cellular imaging

Supplementary files

Article information

Article type
Communication
Submitted
03 Dec 2011
Accepted
03 Feb 2012
First published
20 Feb 2012

Chem. Commun., 2012,48, 3218-3220

A DTTA-ligated uridinequantum dot conjugate as a bimodal contrast agent for cellular imaging

J. Park, S. Bhuniya, H. Lee, Y. Noh, Y. T. Lim, J. H. Jung, K. S. Hong and J. S. Kim, Chem. Commun., 2012, 48, 3218 DOI: 10.1039/C2CC17555J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements